Healt


 Primary Health Care Limited Rallies Post AGM

Primary Health Care Limited Rallies Post AGM

November 22, 2018 03:16 AM AEDT| By Team Kalkine Media

Primary Health Care Limited (ASX: PRY) had its AGM on November 22, 2018, i.e. today. Managing Director and CEO of PRY, Mr. Malcolm Parmenter, while addressing the shareholders in its 2nd AGM, presented the performance of the company in the year 2018,...

 Update on 3 Healthcare Stocks – MMJ, MXC and BOT

Update on 3 Healthcare Stocks – MMJ, MXC and BOT

November 21, 2018 03:07 PM AEDT| By Team Kalkine Media

MMJ Group Holdings Limited (ASX: MMJ) MMJ Group Holdings Limited (ASX: MMJ) is a holding company involved in global cannabis investments. As on 21 November 2018, the company announced that the suspension of trading in the securities of MMJ would be...

 Allegra Orthopaedics Limited At 52 Week High

Allegra Orthopaedics Limited At 52 Week High

November 21, 2018 01:31 PM AEDT| By Team Kalkine Media

Allegra Orthopaedics Limited (ASX: AMT), the provider of a wide range of orthopaedic products ?including the Active Total Knee, is also the exclusive distributor of Waldemar Link Gmbh &Co. KG products in Australia. Link has an extensive range of...

 Heathley Healthcare REIT Initial Public Offering Put On Hold

Heathley Healthcare REIT Initial Public Offering Put On Hold

November 21, 2018 12:47 PM AEDT| By Team Kalkine Media

As per the recent update, Hospital's landlord Heathley Healthcare REIT has postponed its attempted listing on the Australian Securities Exchange. It came into the picture of the company that the unit holders were off the decision on Wednesday. The b...

 Dimerix Trading In Green After Securing Orphan Drug Designation In Europe For DMX-200

Dimerix Trading In Green After Securing Orphan Drug Designation In Europe For DMX-200

November 21, 2018 04:58 AM AEDT| By Team Kalkine Media

On November 21, 2018 i.e. today DXB has made an announcement that the European Commission after receiving highly positive views from the European Medicine Agency?s (EMA) Committee for Orphan Medicinal Products (COMP) in the month of October has final...

 Pro Medicus Shares Mounted On ASX After Announcing A 7-year Contract With Partners Healthcare

Pro Medicus Shares Mounted On ASX After Announcing A 7-year Contract With Partners Healthcare

November 20, 2018 03:46 AM AEDT| By Team Kalkine Media

On 20 November 2018, the leading medical imaging IT provider Pro Medicus Limited (ASX: PME) announced that its wholly owned US subsidiary, Visage Imaging, Inc., has signed an AUD $27m, 7-year contract with Partners Healthcare. Following the release o...

 Can the Japanese Deal Carve-Out New Potential Growth For Regeneus Ltd?

Can the Japanese Deal Carve-Out New Potential Growth For Regeneus Ltd?

November 19, 2018 01:51 PM AEDT| By Team Kalkine Media

Regeneus Limited (ASX: RGS), a clinical-stage regenerative medicine company, has a strong product basket which includes its proprietary stem cell and the immuno-oncology technologies. Technologies used by RGS such as allogeneic stem cell and secretio...

 3 Interesting Healthcare/Biotech Stocks - KZA, BIT And VHT

3 Interesting Healthcare/Biotech Stocks - KZA, BIT And VHT

November 19, 2018 01:43 PM AEDT| By Team Kalkine Media

Healthcare/Biotechnology stocks are attracting investors from everywhere due to the longer life spans and ageing population. These are especially attractive to investors looking for explosive gains and are somewhat risk tolerant. Let?s look at three...

 Healthscope Limited Releases The Progress Report On Its latest Takeover Offer

Healthscope Limited Releases The Progress Report On Its latest Takeover Offer

November 19, 2018 08:57 AM AEDT| By Team Kalkine Media

Healthscope Limited (ASX:HSO) has released an update on its recently received ?takeover offer? from the Brookfield Capital partners. The company has received this takeover offer on November 12, 2018. Under this offered deed the Brookfield Capital Par...

 Baby Bunting Group’s Shares Mounted On ASX After Announcing An Improved Sales Outlook For FY 2019

Baby Bunting Group’s Shares Mounted On ASX After Announcing An Improved Sales Outlook For FY 2019

November 19, 2018 06:24 AM AEDT| By Team Kalkine Media

Baby Bunting Group Ltd (ASX: BBN) held its annual general meeting (AGM) on 19 November 2018. At the Annual General Meeting, the company informed about its improved sales outlook with EBITDA now expected to be in the range of $25.0 million to $27.0 mi...

 More Discoveries On Horizon In Medical Cannabis Research

More Discoveries On Horizon In Medical Cannabis Research

November 19, 2018 03:51 AM AEDT| By Team Kalkine Media

To improve the treatment of everything from anxiety to multiple sclerosis, medical cannabis is already used. MGC Pharma says there are more cannabis-focused medical discoveries with which the medical research is set to receive a big lift. Today the...

 ASX: RAP - A Sinusoidal Trend Witnessed Post Performance Update Release

ASX: RAP - A Sinusoidal Trend Witnessed Post Performance Update Release

November 16, 2018 09:05 AM AEDT| By Team Kalkine Media

ResApp Health Limited (ASX: RAP) has recently presented an update on its performance from various studies and approvals received as on November 15, 2018. While addressing the shareholders, Chief Executive Officer and Managing Director of RAP, Tony K...

 Mesoblast’s Strong Quarter Results Failed To Lift The Share Price

Mesoblast’s Strong Quarter Results Failed To Lift The Share Price

November 16, 2018 08:46 AM AEDT| By Team Kalkine Media

Mesoblast Limited (ASX: MSB) presented its financial and operating metrics for the first quarter ended on September 30, 2018 on November 16, 2018, i.e. today. MSB reported an increase of US$10.5m in revenues up to US$11.6 million for the first quart...

 Pharmaxis’ Upside Move After The Positive Trial Results

Pharmaxis’ Upside Move After The Positive Trial Results

November 15, 2018 12:07 PM AEDT| By Team Kalkine Media

On November 15, 2018, Pharmaxis Limited (ASX: PXS) announced about the Phase 1 clinical trial results. The trial was done to study the outcome from the inhibitor compound LOXL2 (Lysyl Oxidase Like 2) that is used for the treatment of fibrotic disease...

 Paradigm Biopharmaceuticals Slips On ASX Post Announcement About R&D Tax Incentive Refund

Paradigm Biopharmaceuticals Slips On ASX Post Announcement About R&D Tax Incentive Refund

November 15, 2018 06:39 AM AEDT| By Team Kalkine Media

Paradigm Biopharmaceuticals Ltd (ASX: PAR) has received R&D tax incentive refund from the Australian Government on November 15, 2018, i.e. today. The company has received a R&D tax incentive refund of $2.32m. The refund from the Aussie autho...

 Creso Pharma Slips After An Agreement With Virbac

Creso Pharma Slips After An Agreement With Virbac

November 15, 2018 05:54 AM AEDT| By Team Kalkine Media

Creso Pharma Limited (ASX: CPH) has entered into an exclusive distribution agreement with the Virbac Group and the announcement for the same was made on November 14, 2018. Under this distribution agreement, expansion of the commercialization and dist...

 Imugene Rebounds On Receiving Tax Rebate And Advancement To Phase 2 In Gastric Cancer Trial

Imugene Rebounds On Receiving Tax Rebate And Advancement To Phase 2 In Gastric Cancer Trial

November 14, 2018 05:04 AM AEDT| By Team Kalkine Media

Imugene Limited (ASX: IMU), the immuno-oncology company, with its unique technological platform basically tries to harness the immune system of the cancer patients and helps in the generation of the antibodies that can fight against tumors and comple...

 Factor Therapeutics Limited Witnessed A Free Fall After Failed Clinical Trial Results

Factor Therapeutics Limited Witnessed A Free Fall After Failed Clinical Trial Results

November 14, 2018 04:24 AM AEDT| By Team Kalkine Media

Factor Therapeutics Limited (ASX: FTT) has its lead program called ?VF001? that has been developed for the treatment of ulcers. The lead program VF001 is currently in stage 2. On November 14, 2018, FTT presented the results from the clinical trial co...

 Ramsay Health Care Ltd Shares Advance Higher Post Annual General Meeting

Ramsay Health Care Ltd Shares Advance Higher Post Annual General Meeting

November 14, 2018 02:24 AM AEDT| By Team Kalkine Media

Ramsay Health Care Limited (ASX: RHC) held its Annual general meeting on 14 November 2018, following which the share price of the company were seen to be uplifted by 1.334 percent (1:10 PM AEST). In FY 2018, Ramsay Health Care reported a Core Net Pro...

 3 Healthcare Stocks - NAN, BNO And SOM

3 Healthcare Stocks - NAN, BNO And SOM

November 13, 2018 02:09 PM AEDT| By Team Kalkine Media

Nanosonics Limited (ASX: NAN) Nanosonics Limited (ASX: NAN) is a health care company which received very pleasing results in FY 2018 with sales of $60.7 million and a pre-tax profit of $5.6 million contributing to a further increase in the cash bala...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.